Cases of coronavirus continue to rise in many countries all over the world since its outbreak in 2019. However, as the world waits for a cure or vaccine, a scientist from Wuhan has warned that more viruses may make the jump from animals to humans.
According to Dr. Shu Zhengli, a virologist from Wuhan, China, where the virus was first reported, more similar coronaviruses may make the leap from animals to humans. Dr. Shu warned that viruses similar to COVID-19 may be found circulating amongst animals that are in South Asian countries. The virologist made these remarks while speaking at a virtual seminar hosted by French medical and veterinary schools. However, even with her warnings, Dr. Shu and her team have not found the virus in local animals or wildlife.
There has yet to be a definitive origin of the Sars-CoV-2 virus, which causes COVID-19. It is widely believed that the virus was transmitted from bats found in Wuhan; however, Dr. Shu and other scientists believe that the virus was transmitted from bats to humans through another animal. So far, pangolins have been theorized to be the missing link between the transmission of the virus from bats to humans. This is because the scales of pangolins are seen as a local delicacy and as a staple in traditional Chinese medicines.
Although Dr. Shu did not confirm that pangolins were the intermediary animal, she suggested that the virus may have been present in the animal for a while. This was also echoed by another scientist, Professor Edward Holmes of the University of Sydney, who said that it is possible that the first process of cross-transmission did not happen in Wuhan, but rather in Hubei. However, Professor Holmes noted that should it have occurred in Hubei, then there are more possible animals to test.
Meanwhile, millions of people remain infected with COVID-19, and doctors are still struggling to find a cure among existing medications until a vaccine is developed. Previously, a study by researchers from the University of Oxford looked into the possibility of a drug used to treat gout as a possible coronavirus cure. The drug, known as Colchicine, was being added to the list of medicines that are being tested as part of the university’s RECOVERY program, the biggest clinical trial for COVID-19 patients.


Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy
Neuralink Expands Brain Implant Trials with 12 Global Patients
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Lab-grown meat: you may find it icky, but it could drive forward medical research
Tabletop particle accelerator could transform medicine and materials science
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 



